Demonstrate the safety, feasibility and usability of the EPD D700 system, for the first time in humans, in subjects undergoing ablation for the treatment of atrial flutter. Prospective, single-center, non-randomized, open label, single arm study. Ten consented subjects who are scheduled to undergo ablation due to atrial flutter. All subjects will undergo baseline assessment; intervention (standard fluoroscopy guided RF ablation procedure) and post procedure follow up. All subjects will have a follow up visit within 24 hours post procedure.
All procedures will be performed under standard fluoroscopic guidance for the treatment of atrial flutter ablation procedure, and the D700 system will be used additionally to demonstrate system safety, feasibility and usability. The entire procedure will be conducted as customary, using standard and approved off- the-shelf equipment (body surface electrodes, diagnostic and irrigated ablation catheters, RF generator and recording system), in a completely clinically independent manner from the D700 system that will merely be a 'silent witness'. The operator will neither use nor rely on any of the D700 system output for clinical decision making.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Safety Endpoint - Any intra-procedural or immediate post-procedure complications.
Time frame: Intra-procedural or immediate post-procedure
Feasibility - Freedom from any impact on current workflow or clinical efficacy.
Time frame: Intra-procedural or immediate post-procedure
Usability - Correct visualization of the catheter spatial location (map reference).
Time frame: Intra-procedural or immediate post-procedure
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.